Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Alignment Healthcare	Oscar Health	Clover Health Investments	Trupanion	Advanzeon Solutions
Symbol	NASDAQ:ALHC	NYSE:OSCR	NASDAQ:CLOV	NASDAQ:TRUP	OTCMKTS:CHCR
Price Information
Current Price	$20.51	$15.25	$7.92	$114.95	$0.04
50-Day Moving Average	$23.03	$21.89	$10.66	$106.57	$0.06
52-Week Low	$16.32	$15.16	$6.31	$53.54	$0.02
52-Week High	$28.59	$37.00	$28.85	$126.53	$0.29
MarketRank™
Overall Score	2.1	2.1	1.4	2.0	1.0
Analysis Score	3.3	3.4	1.9	1.3	0.0
Community Score	5.0	5.0	4.3	4.7	4.3
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	1.7	0.0	3.3	0.8
Earnings & Valuation Score	0.6	0.6	0.6	0.6	0.0
Analyst Ratings
Consensus Recommendation	Buy	Buy	Hold	Buy	N/A
Consensus Price Target	$31.00	$37.83	$9.50	$112.50	N/A
% Upside from Price Target	51.15% upside	148.09% upside	19.95% upside	-2.13% downside	N/A
Trade Information
Market Cap	$3.84 billion	$3.16 billion	$3.23 billion	$4.60 billion	$5.35 million
Beta	N/A	N/A	1	1.89	2.28
Average Volume	391,657	1,000,075	36,209,953	367,434	23,203
Sales & Book Value
Annual Revenue	$959.22 million	$462.80 million	N/A	$502.03 million	$300,000.00
Price / Sales	4.00	6.83	N/A	9.17	17.83
Cashflow	N/A	N/A	N/A	$0.03 per share	N/A
Price / Cash	N/A	N/A	N/A	3,297.45	N/A
Book Value	N/A	N/A	$0.20 per share	$9.55 per share	($0.40) per share
Price / Book	∞	∞	N/A	12.04	-0.11
Profitability
Net Income	$-22,930,000.00	$-406,830,000.00	$-6,740,000.00	$-5,840,000.00	$-3,260,000.00
EPS	N/A	N/A	N/A	($0.16)	N/A
Trailing P/E Ratio	0.00	0.00	0.00	N/A	0.00
Forward P/E Ratio	N/A	N/A	N/A	N/A	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	-3.15%	N/A
Return on Equity (ROE)	N/A	N/A	-17.88%	-7.13%	N/A
Return on Assets (ROA)	N/A	N/A	-3.19%	-4.24%	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.41%	N/A	0.04%	N/A	N/A
Current Ratio	3.56%	1.63%	4.68%	2.07%	N/A
Quick Ratio	3.56%	1.63%	4.68%	2.07%	N/A
Ownership Information
Institutional Ownership Percentage	77.53%	69.23%	38.20%	77.35%	N/A
Insider Ownership Percentage	N/A	N/A	N/A	6.77%	16.50%
Miscellaneous
Employees	775	1,839	458	911	2
Shares Outstanding	187.27 million	207.38 million	408.10 million	40.06 million	119.91 million
Next Earnings Date	8/9/2021 (Confirmed)	8/12/2021 (Confirmed)	8/11/2021 (Confirmed)	8/5/2021 (Confirmed)	N/A
Optionable	Not Optionable	Not Optionable	Not Optionable	Optionable	Not Optionable

Source	Headline
	News for Comprehensive Care Corp markets.businessinsider.com - December 24 at 7:55 AM
	Insider Buys Advanzeon Solutions Stock finance.yahoo.com - September 16 at 12:49 AM
	Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary Material Streamlining of its Sleep Apnea Screening and Testing Process to Accommodate Increased Patient Volume finance.yahoo.com - August 17 at 6:06 PM
	Advanzeon Solutions, Inc.’s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Announces Medical Director and www.bloomberg.com - June 7 at 6:00 PM
	Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary's SleepMaster Solutions(TM) Sleep Apnea Program Extended by Promin www.bloomberg.com - May 25 at 12:30 AM
	Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Announces Launch of Its SleepMaster Solutions Program with CoreChoice finance.yahoo.com - April 29 at 10:51 AM
	Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary Fast Forwards its Efforts to Help Combat COVID-19 finance.yahoo.com - April 13 at 2:21 PM
	Advanzeon Solutions, Inc.’s Message from its CEO Regarding the Fight Against COVID-19 apnews.com - April 2 at 2:04 AM
	Advanzeon Solutions, Inc.'s Message from its CEO Regarding the Fight Against COVID-19 finance.yahoo.com - April 1 at 4:04 PM
	Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary Announces Exclusive 3-Year Contract with CoreChoice www.finanznachrichten.de - February 27 at 12:39 AM
	Advanzeon Solutions, Inc.’s Wholly Owned Subsidiary Announces Exclusive 3-Year Contract with CoreChoice finance.yahoo.com - February 26 at 2:38 PM
	Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Hires New Chief Market www.bloomberg.com - February 14 at 9:26 PM
	Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Hires New Chief Marketing Officer finance.yahoo.com - December 9 at 12:27 PM
	Advanzeon Solutions, Inc.s' Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces Exclusive 3-Year Contract with Pinnacle National finance.yahoo.com - October 16 at 1:10 PM
	Advanzeon Solutions Inc markets.ft.com - October 12 at 10:53 PM
	Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces New National Manager of Sales and Marketing finance.yahoo.com - September 20 at 4:44 AM
	Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces Strategic Relationship with Crank Communications finance.yahoo.com - August 19 at 4:29 PM
	Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary's SleepMaster Solutions(TM) Sleep Apnea Program Extended by Prominent Teamsters Health and Welfare Trust Fund finance.yahoo.com - July 24 at 4:28 PM
	Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary's SleepMaster Solutions (TM) Sleep Apnea Program has been Selected by All Aboard America! for its Drivers and Employees finance.yahoo.com - July 8 at 10:54 AM
	Advanzeon Solutions, Inc. Brings Financial Filings Current finance.yahoo.com - June 18 at 9:42 PM
	Advanzeon Solutions, Inc. Announces Management and Infrastructure Enhancements and Lease Extension finance.yahoo.com - May 31 at 4:21 PM

Date	Company	Brokerage	Action
7/12/2021	Clover Health Investments	JPMorgan Chase & Co.	Downgrade
7/2/2021	Alignment Healthcare	Morgan Stanley	Boost Price Target
6/10/2021	Clover Health Investments	Bank of America	Downgrade
5/24/2021	Clover Health Investments	Bank of America	Reiterated Rating
5/19/2021	Clover Health Investments	Credit Suisse Group	Lower Price Target
5/18/2021	Alignment Healthcare	Raymond James	Boost Price Target
5/18/2021	Clover Health Investments	Citigroup	Lower Price Target
5/17/2021	Clover Health Investments	Bank of America	Downgrade
4/20/2021	Alignment Healthcare	Raymond James	Initiated Coverage
4/20/2021	Alignment Healthcare	Morgan Stanley	Initiated Coverage
4/20/2021	Alignment Healthcare	Bank of America	Initiated Coverage
4/20/2021	Alignment Healthcare	William Blair	Initiated Coverage
4/20/2021	Alignment Healthcare	UBS Group	Initiated Coverage
4/20/2021	Alignment Healthcare	The Goldman Sachs Group	Initiated Coverage
4/20/2021	Alignment Healthcare	Piper Sandler	Initiated Coverage
4/5/2021	Trupanion	Evercore ISI	Initiated Coverage
3/29/2021	Oscar Health	Wells Fargo & Company	Initiated Coverage
3/29/2021	Oscar Health	Bank of America	Initiated Coverage
3/29/2021	Oscar Health	Morgan Stanley	Initiated Coverage
3/29/2021	Oscar Health	Cowen	Initiated Coverage
3/29/2021	Oscar Health	The Goldman Sachs Group	Initiated Coverage
3/29/2021	Oscar Health	Credit Suisse Group	Initiated Coverage
3/9/2021	Clover Health Investments	Credit Suisse Group	Initiated Coverage
3/3/2021	Clover Health Investments	Citigroup	Lower Price Target
2/11/2021	Trupanion	Lake Street Capital	Boost Price Target
2/11/2021	Trupanion	Canaccord Genuity	Boost Price Target
2/2/2021	Clover Health Investments	Citigroup	Initiated Coverage
2/1/2021	Clover Health Investments	JPMorgan Chase & Co.	Initiated Coverage
11/2/2020	Trupanion	Canaccord Genuity	Boost Price Target
10/30/2020	Trupanion	Lake Street Capital	Boost Price Target
8/10/2020	Trupanion	Guggenheim	Downgrade
8/5/2020	Trupanion	Canaccord Genuity	Boost Price Target
8/5/2020	Trupanion	Lake Street Capital	Boost Price Target
8/5/2020	Trupanion	Northland Securities	Downgrade
7/30/2020	Trupanion	Stifel Nicolaus	Boost Price Target
6/25/2020	Trupanion	Northland Securities	Initiated Coverage
6/15/2020	Trupanion	Royal Bank of Canada	Reiterated Rating
6/9/2020	Trupanion	Northland Securities	Initiated Coverage
5/1/2020	Trupanion	Lake Street Capital	Reiterated Rating
5/1/2020	Trupanion	Royal Bank of Canada	Boost Price Target
5/1/2020	Trupanion	Northland Securities	Reiterated Rating
4/27/2020	Trupanion	Royal Bank of Canada	Reiterated Rating
4/8/2020	Trupanion	Royal Bank of Canada	Reiterated Rating
4/6/2020	Trupanion	Northland Securities	Reiterated Rating
3/2/2020	Trupanion	Canaccord Genuity	Reiterated Rating
2/14/2020	Trupanion	Lake Street Capital	Boost Price Target
2/14/2020	Trupanion	Canaccord Genuity	Reiterated Rating
2/14/2020	Trupanion	Raymond James	Downgrade
1/8/2020	Trupanion	Stifel Nicolaus	Downgrade
11/18/2019	Trupanion	Guggenheim	Boost Price Target
2/13/2019	Clover Health Investments	HC Wainwright	Initiated Coverage

(Data available from 8/4/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources